Teva Pharmaceutical Industries Limited American Depositary Shares

11.11-0.4200-3.64%Vol 8.87M1Y Perf -0.66%
Jun 11th, 2021 16:00 DELAYED
BID11.16 ASK11.22
Open11.40 Previous Close11.53
Pre-Market- After-Market11.20
 - -  0.09 0.81%
Target Price
12.14 
Analyst Rating
Hold 2.65
Potential %
9.27 
Finscreener Ranking
     33.35
Insiders Trans % 3/6/12 mo.
-100/-100/-100 
Value Ranking
+     38.02
Insiders Value % 3/6/12 mo.
-100/-100/-100 
Growth Ranking
     24.96
Insiders Shares Cnt. % 3/6/12 mo.
-100/-100/-100 
Income Ranking
 —    -
Market Cap12.13B 
Earnings Rating
Sell
Price Range Ratio 52W %
54.94 
Earnings Date
4th Aug 2021

Today's Price Range

11.1011.45

52W Range

8.4413.30

5 Year PE Ratio Range

-6.90547.30

Summary:

Buy

Technical Indicators: Neutral
Moving Averages: Strong Buy
Performance
1 Week
6.83%
1 Month
8.18%
3 Months
2.97%
6 Months
7.55%
1 Year
-0.66%
3 Years
-53.75%
5 Years
-78.93%
10 Years
-74.82%

TickerPriceChg.Chg.%
TEVA11.11-0.4200-3.64
AAPL127.351.24000.98
GOOG2 513.93-7.6700-0.30
MSFT257.890.65000.25
XOM62.17-0.5800-0.92
WFC45.680.59001.31
JNJ164.96-2.1200-1.27
FB331.26-1.2000-0.36
GE13.690.06000.44
JPM160.29-0.1100-0.07
Financial StrengthValueIndustryS&P 500US Markets
0.50
1.00
0.69
2.54
-3.00
Leverage Ratio 4.70
ProfitabilityValueIndustryS&P 500US Markets
44.20
-19.70
-10.20
-19.30
-24.54
RevenueValueIndustryS&P 500US Markets
16.28B
14.85
-6.82
-3.07
Earnings HistoryEstimateReportedSurprise %
Q01 20210.550.609.09
Q04 20200.610.644.92
Q03 20200.560.560.00
Q02 20200.500.524.00
Q01 20200.570.7328.07
Q04 20190.590.613.39
Q03 20190.580.56-3.45
Q02 20190.550.573.64
Earnings Per EndEstimateRevision %Trend
6/2021 QR0.56-5.08Negative
9/2021 QR0.66-1.49Negative
12/2021 FY2.540.00-
12/2022 FY2.733.02Positive
Next Report Date4th Aug 2021
Estimated EPS Next Report0.56
Estimates Count4
EPS Growth Next 5 Years %4.70
Volume Overview
Volume8.87M
Shares Outstanding1.09B
Trades Count32.06K
Dollar Volume135.69M
Avg. Volume9.07M
Avg. Weekly Volume9.50M
Avg. Monthly Volume6.93M
Avg. Quarterly Volume7.86M

Teva Pharmaceutical Industries Limited American Depositary Shares (NYSE: TEVA) stock closed at 11.11 per share at the end of the most recent trading day (a -3.64% change compared to the prior day closing price) with a volume of 8.99M shares and market capitalization of 12.13B. Is a component of indices and it is traded on NYSE exchange. The company belongs in the Drug Manufacturers industry, Healthcare sector and employs 40216 people. Teva Pharmaceutical Industries Limited American Depositary Shares CEO is Kare Schultz.

The one-year performance of Teva Pharmaceutical Industries Limited American Depositary Shares stock is -0.66%, while year-to-date (YTD) performance is 15.13%. TEVA stock has a five-year performance of -78.93%. Its 52-week range is between 8.44 and 13.3, which gives TEVA stock a 52-week price range ratio of 54.94%

Teva Pharmaceutical Industries Limited American Depositary Shares currently has a PE ratio of -2.90, a price-to-book (PB) ratio of 1.16, a price-to-sale (PS) ratio of 0.72, a price to cashflow ratio of 22.90, a PEG ratio of 2.32, a ROA of -7.38%, a ROC of -7.86% and a ROE of -32.65%. The company’s profit margin is -24.54%, its EBITDA margin is -10.20%, and its revenue ttm is $16.28 Billion , which makes it $14.85 revenue per share.

Of the last four earnings reports from Teva Pharmaceutical Industries Limited American Depositary Shares, there were 3 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $0.56 for the next earnings report. Teva Pharmaceutical Industries Limited American Depositary Shares’s next earnings report date is 04th Aug 2021.

The consensus rating of Wall Street analysts for Teva Pharmaceutical Industries Limited American Depositary Shares is Hold (2.65), with a target price of $12.14, which is +9.27% compared to the current price. The earnings rating for Teva Pharmaceutical Industries Limited American Depositary Shares stock is Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Teva Pharmaceutical Industries Limited American Depositary Shares has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Teva Pharmaceutical Industries Limited American Depositary Shares has a Buy technical analysis rating based on Technical Indicators (ADX : 7.99, ATR14 : 0.36, CCI20 : 216.10, Chaikin Money Flow : 0.01, MACD : 0.11, Money Flow Index : 51.68, ROC : 6.01, RSI : 56.78, STOCH (14,3) : 63.03, STOCH RSI : 0.57, UO : 49.61, Williams %R : -36.97), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Teva Pharmaceutical Industries Limited American Depositary Shares in the last 12-months were: Amir Elstein (Option Excercise at a value of $0), Brendan P. O'Grady (Option Excercise at a value of $0), Brendan P. O'Grady (Sold 55 850 shares of value $638 421 ), David Matthew Stark (Option Excercise at a value of $0), David Matthew Stark (Sold 121 052 shares of value $1 407 083 ), Eric Drape (Option Excercise at a value of $0), Eric Drape (Sold 86 045 shares of value $960 020 ), Gerald M. Lieberman (Option Excercise at a value of $0), Gianfranco Nazzi (Option Excercise at a value of $0), Gianfranco Nazzi (Sold 35 970 shares of value $427 357 ), Hafrun Fridriksdottir (Option Excercise at a value of $0), Hafrun Fridriksdottir (Sold 110 175 shares of value $1 234 029 ), Janet S. Vergis (Option Excercise at a value of $0), Jean-Michel Halfon (Option Excercise at a value of $0), Kare Schultz (Option Excercise at a value of $0), Mark Sabag (Option Excercise at a value of $0), Mark Sabag (Sold 127 244 shares of value $1 427 614 ), Nechemia (Chemi) J. Peres (Option Excercise at a value of $0), Nechemia J. Peres (Option Excercise at a value of $0), Perry D. Nisen (Option Excercise at a value of $0), Richard Daniell (Option Excercise at a value of $0), Richard Daniell (Sold 77 261 shares of value $963 705 ), Roberto A. Mignone (Option Excercise at a value of $0), Roberto Mignone (Option Excercise at a value of $0), Ronit Satchi-Fainaro (Option Excercise at a value of $0), Rosemary A. Crane (Option Excercise at a value of $0), Rosemary A. Crane (Sold 5 720 shares of value $68 075 ), Sol J. Barer (Option Excercise at a value of $0), Sven Dethlefs (Option Excercise at a value of $0), Sven Dethlefs (Sold 36 275 shares of value $446 587 )

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
4 (21.05 %)
4 (18.18 %)
4 (18.18 %)
Moderate Buy
1 (5.26 %)
1 (4.55 %)
1 (4.55 %)
Hold
12 (63.16 %)
13 (59.09 %)
13 (59.09 %)
Moderate Sell
1 (5.26 %)
1 (4.55 %)
1 (4.55 %)
Strong Sell
1 (5.26 %)
3 (13.64 %)
3 (13.64 %)
Summary RatingHold
2.65
Hold
2.88
Hold
2.88

Teva Pharmaceutical Industries Limited American Depositary Shares

Teva Pharmaceutical Industries Ltd is the largest generic drug manufacturer in the world with roughly 60 manufacturing and R&D facilities. The company was formed in 1901 and has a portfolio of more than 3,500 medicines--roughly 1 out of 9 generic prescriptions in the U.S. is filled with a Teva product. The company also develops branded pharmaceuticals in the central nervous system, oncology, and respiratory categories. Teva's generic drug sales represent slightly over half of total revenue, with branded drug and distribution revenue making up the balance. Teva is an aggressive filer to bring generic drugs to market when brand patents expire and has the most generic products pending Food and Drug Administration approval.

CEO: Kare Schultz

Telephone: +972 39148213

Address: 5 Basel Street, Petach Tikva 4951033, , IL

Number of employees: 40 216

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

62%38%

Bearish Bullish

54%46%

Bearish Bullish

51%49%

News

Stocktwits